8:00 am Registration & Coffee

8:55 am Opening Remarks & Day 1 Summary

Clinical Trial Case Studies
Gain invaluable insights on the most advanced clinical programs to discover how the application of allogeneic cell therapies are being successfully utilized in the clinic.

9:00 am Assessing the Efficacy & Safety of Allogeneic Osteoblastic Cells (ALLOB) Single Implantation in Tibial Fracture

9:30 am Allogeneic, Off-the-Shelf T-Cell Immunotherapy Cell Therapies & Derivation of a Next- Generation CAR-T Platform

  • Blake Aftab VP, Preclinical & Translational Science, Atara Biotherapeutics

10:00 am Learnings from Dose Level 1 & Dose Level 2 of the Phase 1 Trial of PBCAR0191, an Allogeneic CD19 CAR-T for the Treatment of Relapsed/Refractory NHL & ALL

10:30 am Tech Slam

11:00 am Morning Refreshments & Networking

12:30 pm Lunch & Networking

2:00 pm Afternoon Refreshments & Networking

3:00 pm FDA Perspective on Allogeneic Regulatory Expectations

3:30 pm Close of Summit